BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19556935)

  • 1. Diagnostic methodologies for chlamydia screening in females aged 15 to 25 years from private insurance claims data in the United States, 2001 to 2005.
    Owusu-Edusei K; Bohm MK; Kent CK
    Sex Transm Dis; 2009 Jul; 36(7):419-21. PubMed ID: 19556935
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlamydia testing patterns for commercially insured women, 2008.
    Tao G; Hoover KW; Kent CK
    Am J Prev Med; 2012 Apr; 42(4):337-41. PubMed ID: 22424245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of regular chlamydia testing by U.S. women: a longitudinal study.
    Heijne JC; Tao G; Kent CK; Low N
    Am J Prev Med; 2010 Sep; 39(3):243-50. PubMed ID: 20709256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia screening among sexually active young female enrollees of health plans--United States, 2000-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):362-5. PubMed ID: 19373196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systematic screening for Chlamydia trachomatis with the molecular biological AMP-CT test in urine samples from young women].
    Orfila J; Mention JE; Sueur JM; Chaigneau C
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):555-7. PubMed ID: 12407326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What about the men?
    Dunne EF; Gift TL; Stamm WE
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S1-2. PubMed ID: 18813144
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular tests for detection of the sexually-transmitted pathogens Neisseria gonorrhoeae and Chlamydia trachomatis.
    Chapin KC
    Med Health R I; 2006 Jun; 89(6):202-4. PubMed ID: 16875007
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlamydia testing urged for military.
    AIDS Patient Care STDS; 2004 Jan; 18(1):60. PubMed ID: 15080098
    [No Abstract]   [Full Text] [Related]  

  • 9. Chlamydia trachomatis positivity rates among men tested in selected venues in the United States: a review of the recent literature.
    Rietmeijer CA; Hopkins E; Geisler WM; Orr DP; Kent CK
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S8-S18. PubMed ID: 18449072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens.
    Berger RE
    J Urol; 2005 Jun; 173(6):1989-90. PubMed ID: 15879801
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of APTIMA COMBO 2 assay with polymerase chain reaction Roche assay for detection of Chlamydia trachomatis in endocervical swabs.
    Khryanin AA; Reshetnikov OV; Vlaspolder F
    Int J STD AIDS; 2007 Dec; 18(12):871-2. PubMed ID: 18073027
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlamydia screening among sexually active young female enrollees of health plans--United States, 1999-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(42):983-5. PubMed ID: 15514579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic examination findings and Chlamydia trachomatis infection in asymptomatic young women screened with a nucleic acid amplification test.
    Geisler WM; Chow JM; Schachter J; McCormack WM
    Sex Transm Dis; 2007 Jun; 34(6):335-8. PubMed ID: 17028510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efforts by commercial health plans to increase Chlamydia trachomatis screening among their members.
    Atherly A; Blake SC
    Sex Transm Dis; 2013 Jan; 40(1):55-60. PubMed ID: 23254117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex and age correlates of Chlamydia prevalence in adolescents and adults entering correctional facilities, 2005: implications for screening policy.
    Joesoef MR; Weinstock HS; Kent CK; Chow JM; Boudov MR; Parvez FM; Cox T; Lincoln T; Miller JL; Sternberg M;
    Sex Transm Dis; 2009 Feb; 36(2 Suppl):S67-71. PubMed ID: 19125147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia screening programme, HMP Hydebank Wood Young Offender Centre, Belfast, Northern Ireland, UK.
    Hirst H; Dinsmore WW
    Int J STD AIDS; 2009 May; 20(5):360-1. PubMed ID: 19386977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising Chlamydia testing within constrained funding.
    Morris AJ; McCarthy M
    N Z Med J; 2006 Jul; 119(1238):U2093. PubMed ID: 16868586
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among adolescents in Family Court, Philadelphia, Pennsylvania.
    Johnson CC; Jones EH; Goldberg M; Asbel LE; Salmon ME; Waller CL
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S24-7. PubMed ID: 18607316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questioning the value of screening for gonorrhoea in symptomless heterosexual men.
    Evans-Jones J
    Int J STD AIDS; 2010 Apr; 21(4):302. PubMed ID: 20378909
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction in unnecessary Chlamydia screening among older women at title X-funded family planning sites following a structural intervention--San Francisco, 2009.
    Bernstein KT; Marcus JL; Snell A; Liska S; Rauch L; Philip SS
    Sex Transm Dis; 2011 Feb; 38(2):127-9. PubMed ID: 21139515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.